Herold Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Herold Advisors's PFE Position: Q1 2026 in Review
Herold Advisors increased its Pfizer (PFE) stake by 5.1% in Q1 2026, buying an estimated $97K and bringing the position to 75,030 shares worth $2.11M. The position accounts for 0.46% of the portfolio, ranked #60.
Herold Advisors first reported a position in PFE in Q3 2021 and has held it in 19 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Herold Advisors held 75,030 shares of Pfizer worth $2.11M as of Q1 2026.
- Herold Advisors bought 3,642 Pfizer shares in Q1 2026, an estimated $97K.
- Pfizer made up 0.46% of Herold Advisors's portfolio in Q1 2026, its #60 holding.
- Herold Advisors first reported a position in Pfizer in Q3 2021 and has held it in 19 quarters since.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Herold Advisors's 13F filing for Q1 2026, filed 15 May 2026.